NanoCarrier Co., Ltd. (4571.T)
JPY 150.0
(-1.96%)
JPY 150.0
(-1.96%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 135.5 Million JPY | -32.98% |
| 2022 | 202.18 Million JPY | -23.42% |
| 2021 | 264.03 Million JPY | -15.72% |
| 2020 | 313.26 Million JPY | -43.35% |
| 2019 | 552.97 Million JPY | 11.32% |
| 2018 | 496.73 Million JPY | 91.72% |
| 2017 | 259.09 Million JPY | 18.47% |
| 2016 | 218.69 Million JPY | -10.13% |
| 2015 | 243.34 Million JPY | -63.99% |
| 2014 | 675.8 Million JPY | 43.12% |
| 2013 | 472.19 Million JPY | 26.33% |
| 2012 | 373.77 Million JPY | 7.92% |
| 2011 | 346.34 Million JPY | 310.67% |
| 2010 | 84.33 Million JPY | -28.42% |
| 2009 | 117.82 Million JPY | -66.68% |
| 2008 | 353.64 Million JPY | 34.61% |
| 2007 | 262.71 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | - JPY | -100.0% |
| 2023 Q3 | 13.2 Million JPY | -59.01% |
| 2023 Q4 | 31.2 Million JPY | 136.36% |
| 2023 Q1 | 58.9 Million JPY | -1.95% |
| 2023 Q2 | 32.2 Million JPY | -45.34% |
| 2023 FY | 135.5 Million JPY | -32.98% |
| 2022 Q1 | 20.36 Million JPY | -68.11% |
| 2022 Q4 | 60.07 Million JPY | 19.87% |
| 2022 FY | 202.18 Million JPY | -23.42% |
| 2022 Q2 | 71.62 Million JPY | 251.76% |
| 2022 Q3 | 50.11 Million JPY | -30.03% |
| 2021 Q3 | 65.83 Million JPY | 10.72% |
| 2021 Q4 | 63.84 Million JPY | -3.02% |
| 2021 Q2 | 59.45 Million JPY | -20.6% |
| 2021 Q1 | 74.89 Million JPY | 16.67% |
| 2021 FY | 264.03 Million JPY | -15.72% |
| 2020 FY | 313.26 Million JPY | -43.35% |
| 2020 Q2 | 63.89 Million JPY | -50.63% |
| 2020 Q3 | 55.76 Million JPY | -12.72% |
| 2020 Q4 | 64.19 Million JPY | 15.1% |
| 2020 Q1 | 129.41 Million JPY | 9.96% |
| 2019 Q1 | 146.21 Million JPY | -9.08% |
| 2019 Q4 | 117.68 Million JPY | -16.93% |
| 2019 FY | 552.97 Million JPY | 11.32% |
| 2019 Q2 | 147.4 Million JPY | 0.82% |
| 2019 Q3 | 141.66 Million JPY | -3.89% |
| 2018 FY | 496.73 Million JPY | 91.72% |
| 2018 Q4 | 160.82 Million JPY | 36.36% |
| 2018 Q3 | 117.93 Million JPY | -32.97% |
| 2018 Q1 | 42.04 Million JPY | -65.05% |
| 2018 Q2 | 175.93 Million JPY | 318.47% |
| 2017 Q3 | 68.24 Million JPY | 95.29% |
| 2017 Q1 | 35.61 Million JPY | -52.39% |
| 2017 FY | 259.09 Million JPY | 18.47% |
| 2017 Q4 | 120.3 Million JPY | 76.29% |
| 2017 Q2 | 34.94 Million JPY | -1.87% |
| 2016 Q2 | 45.59 Million JPY | 19.09% |
| 2016 Q1 | 38.28 Million JPY | -75.33% |
| 2016 Q4 | 74.78 Million JPY | 24.6% |
| 2016 Q3 | 60.02 Million JPY | 31.64% |
| 2016 FY | 218.69 Million JPY | -10.13% |
| 2015 Q3 | 75.07 Million JPY | 8805.81% |
| 2015 Q1 | 12.24 Million JPY | -96.14% |
| 2015 Q4 | 155.18 Million JPY | 106.7% |
| 2015 Q2 | 843 Thousand JPY | -93.11% |
| 2015 FY | 243.34 Million JPY | -63.99% |
| 2014 Q1 | 56.96 Million JPY | 104.94% |
| 2014 FY | 675.8 Million JPY | 43.12% |
| 2014 Q4 | 317.08 Million JPY | 569.98% |
| 2014 Q3 | 47.32 Million JPY | -81.4% |
| 2014 Q2 | 254.42 Million JPY | 346.65% |
| 2013 FY | 472.19 Million JPY | 26.33% |
| 2013 Q2 | 175.78 Million JPY | 17.23% |
| 2013 Q3 | 118.67 Million JPY | -32.49% |
| 2013 Q4 | 27.79 Million JPY | -76.58% |
| 2013 Q1 | 149.94 Million JPY | -13.2% |
| 2012 FY | 373.77 Million JPY | 7.92% |
| 2012 Q3 | 101.71 Million JPY | 13.62% |
| 2012 Q2 | 89.51 Million JPY | 813.54% |
| 2012 Q4 | 172.74 Million JPY | 69.84% |
| 2012 Q1 | 9.79 Million JPY | -92.72% |
| 2011 Q4 | 134.62 Million JPY | 8058.79% |
| 2011 Q1 | 4.45 Million JPY | -82.99% |
| 2011 FY | 346.34 Million JPY | 310.67% |
| 2011 Q3 | 1.65 Million JPY | -99.2% |
| 2011 Q2 | 205.62 Million JPY | 4518.64% |
| 2010 Q1 | 10.36 Million JPY | -45.7% |
| 2010 Q4 | 26.17 Million JPY | -34.06% |
| 2010 Q3 | 39.69 Million JPY | 389.42% |
| 2010 Q2 | 8.11 Million JPY | -21.73% |
| 2010 FY | 84.33 Million JPY | -28.42% |
| 2009 Q2 | 32.25 Million JPY | 342.46% |
| 2009 Q3 | 59.2 Million JPY | 83.56% |
| 2009 FY | 117.82 Million JPY | -66.68% |
| 2009 Q4 | 19.08 Million JPY | -67.77% |
| 2009 Q1 | 7.28 Million JPY | -89.31% |
| 2008 Q3 | 134.39 Million JPY | 0.0% |
| 2008 Q4 | 68.2 Million JPY | -49.25% |
| 2008 FY | 353.64 Million JPY | 34.61% |
| 2007 FY | 262.71 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 97.159% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -19.997% |
| GNI Group Ltd. | 26.01 Billion JPY | 99.479% |
| Linical Co., Ltd. | 12.3 Billion JPY | 98.899% |
| Trans Genic Inc. | 13.08 Billion JPY | 98.964% |
| MEDINET Co., Ltd. | 661.54 Million JPY | 79.516% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 97.373% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 91.316% |
| AnGes, Inc. | 152.98 Million JPY | 11.424% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | 77.79% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 98.939% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 83.408% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 91.666% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | 68.366% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 92.873% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 80.144% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 94.426% |
| PeptiDream Inc. | 28.71 Billion JPY | 99.528% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -114.962% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -11.99% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -188105.556% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -239.73% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 96.996% |
| FunPep Company Limited | 530 Thousand JPY | -25467.547% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -95.679% |
| Stella Pharma Corporation | 269.49 Million JPY | 49.717% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | 57.228% |
| Cuorips Inc. | 23.1 Million JPY | -486.564% |
| K Pharma,Inc. | 1 Billion JPY | 86.449% |
| Takara Bio Inc. | 43.5 Billion JPY | 99.689% |
| ReproCELL Incorporated | 2.42 Billion JPY | 94.416% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 92.1% |
| StemCell Institute Inc. | 2.48 Billion JPY | 94.539% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 94.61% |
| CellSeed Inc. | 190.13 Million JPY | 28.73% |